SEC 13F Intelligence

Verity & Verity, LLC / ABBV

Verity & Verity, LLC’s Abbvie Inc Position

Does Verity & Verity, LLC own Abbvie Inc (ABBV)? Yes177.4K shares worth $39M (+2.87% of its 13F portfolio) as of Q1 2026, up from 174.7K shares the prior filed quarter.

Position Value
$39M
Q1 2026
Shares
177.4K
% of Portfolio
+2.87%
Quarters Held
29
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $5MQ4 ’19: $6MQ4 ’19Q1 ’20: $6MQ2 ’20: $8MQ3 ’20: $7MQ4 ’20: $10MQ4 ’20Q2 ’21: $11MQ3 ’21: $12MQ4 ’21: $17MQ1 ’22: $21MQ1 ’22Q2 ’22: $20MQ3 ’22: $18MQ4 ’22: $23MQ1 ’23: $23MQ1 ’23Q2 ’23: $21MQ3 ’23: $24MQ4 ’23: $25MQ1 ’24: $23MQ1 ’24Q2 ’24: $27MQ3 ’24: $107MQ4 ’24: $31MQ1 ’25: $36MQ1 ’25Q2 ’25: $32MQ3 ’25: $40MQ4 ’25: $40MQ1 ’26: $39MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026177.4K$39M+2.87%
Q4 2025174.7K$40M+3.10%
Q3 2025173.4K$40M+3.21%
Q2 2025172.2K$32M+2.75%
Q1 2025173.6K$36M+3.19%
Q4 2024171.9K$31M+2.79%
Q3 2024652.3K$107M+3.07%
Q2 2024158.9K$27M+3.03%
Q1 2024142.4K$23M+1.38%
Q4 2023163.1K$25M+2.95%
Q3 2023161.0K$24M+3.06%
Q2 2023158.7K$21M+2.67%
Q1 2023142.4K$23M+2.96%
Q4 2022140.0K$23M+2.95%
Q3 2022134.3K$18M+2.90%
Q2 2022130.5K$20M+3.06%
Q1 2022130.7K$21M+2.94%
Q4 2021129.1K$17M+2.50%
Q3 2021103.0K$12M+1.81%
Q2 2021100.4K$11M+1.84%
Q4 202091.7K$10M+1.89%
Q3 202082.3K$7M+1.59%
Q2 202080.0K$8M+1.87%
Q1 202078.0K$6M+1.68%
Q4 201963.1K$6M+1.08%
Q3 201962.8K$5M+0.97%
Q2 201958.1K$4M+0.92%
Q1 201955.8K$4M+1.03%
Q4 201851.2K$5M+1.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Verity & Verity, LLC’s full portfolio or all institutional holders of ABBV.